Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.

Heart Failure Reviews
Jason J Gajarsa, Robert A Kloner

Abstract

As more patients survive myocardial infarctions, the incidence of heart failure increases. After an infarction, the human heart undergoes a series of structural changes, which are governed by cellular and molecular mechanisms in a pathological metamorphosis termed "remodeling." This review will discuss the current developments in our understanding of these molecular and cellular events in remodeling and the various pharmacological, cellular and device therapies used to treat, and potentially retard, this condition. Specifically, this paper will examine the neurohormonal activity of the renin-angiotensin-aldosterone axis and its molecular effects on the heart. The emerging understanding of the extra-cellular matrix and the various active molecules within it, such as the matrix metalloproteinases, elicits new appreciation for their role in cardiac remodeling and as possible future therapeutic targets. Cell therapy with stem cells is another recent therapy with great potential in improving post-infarcted hearts. Lastly, the cellular and molecular effects of left ventricular assist devices on remodeling will be reviewed. Our increasing knowledge of the cellular and molecular mechanisms underlying cardiac remodeling enables us not o...Continue Reading

References

Jun 1, 1978·The American Journal of Cardiology·G M Hutchins, B H Bulkley
Nov 1, 1991·Circulation·P WhittakerR A Kloner
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Jul 1, 1988·Circulation·H F WeismanB Healy
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·E MascarenoM A Siddiqui
Mar 4, 2000·Circulation Research·S MiyataL A Leinwand
Dec 29, 2000·Journal of the American College of Cardiology·B A GroenningP R Hildebrandt
Apr 20, 2001·Heart Failure Reviews·C S Long
Aug 22, 2001·Trends in Cell Biology·V Baud, M Karin
Feb 20, 2002·Journal of Molecular and Cellular Cardiology·Alfonso BaldiGermano Di Sciascio
Nov 8, 2002·Biochimica Et Biophysica Acta·Michael U Martin, Holger Wesche
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Dec 20, 2003·Basic Research in Cardiology·Rainer SchulzGerd Heusch
Jan 7, 2004·Circulation·Robert N DoughtyUNKNOWN CAPRICORN Echo Substudy Investigators
Feb 24, 2006·Journal of Cardiovascular Pharmacology·Kimberly A AppleFrancis G Spinale
Apr 1, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G SongJ P Spiers
Sep 23, 2006·The New England Journal of Medicine·Volker SchächingerUNKNOWN REPAIR-AMI Investigators
Aug 19, 2007·Journal of the American College of Cardiology·Anna K Y ChanCheuk-Man Yu
Aug 19, 2007·Journal of the American College of Cardiology·Jay N Cohn
Sep 13, 2008·Pharmacology & Therapeutics·Kerstin BoenglerRainer Schulz

❮ Previous
Next ❯

Citations

Jul 23, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Michael BöhmFaiez Zannad
Oct 12, 2012·Journal of Cardiovascular Translational Research·Slava Epelman, Douglas L Mann
Jun 7, 2011·European Heart Journal·Stefan P Janssens
Nov 24, 2012·American Journal of Physiology. Cell Physiology·Edie C GoldsmithFrancis G Spinale
Aug 23, 2012·Cardiovascular Diabetology·Sergio Raposeiras-RoubínJosé R González-Juanatey
Aug 9, 2012·Journal of Translational Medicine·Judy Sc WangNestor F Gonzalez-Cadavid
Apr 30, 2014·Revista Española De Cardiología·David Garcia-DoradoJavier Inserte
Mar 19, 2014·Biochimica Et Biophysica Acta·F Di ScipioG N Berta
Jun 28, 2014·European Heart Journal·Roberto Ferrari, Paola Rizzo
Nov 6, 2012·Heart Failure Reviews·Pasquale AbeteFrancesco Cacciatore
Jun 17, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nobuko TanoKen Suzuki
Aug 6, 2014·Cardiovascular Research·Arash Yavari, Houman Ashrafian
Dec 3, 2014·Carbohydrate Polymers·Amanda K A SilvaDidier Letourneur
May 6, 2014·Current Hypertension Reports·Elena KaschinaU Muscha Steckelings
Oct 19, 2011·Stem Cell Reviews and Reports·Giancarlo ForteTakao Aoyagi
Aug 30, 2012·Herz·S Brenner, G Ertl
Aug 19, 2011·Heart Failure Reviews·Naranjan S DhallaVijayan Elimban
Oct 4, 2012·Expert Review of Cardiovascular Therapy·Shripad N Pal, Theodoros Kofidis
Apr 18, 2014·Expert Review of Cardiovascular Therapy·M Scott HalbreinerNader Moazami
Mar 19, 2016·Cardiology Research and Practice·Alessio Galli, Federico Lombardi
Dec 3, 2014·International Journal of Cardiology·Sam C LatetChristiaan J Vrints
Oct 13, 2014·International Journal of Cardiology·Santiago RouraAntoni Bayes-Genis
Dec 26, 2012·Trends in Cardiovascular Medicine·Evangelos P DaskalopoulosW Matthijs Blankesteijn
Mar 20, 2012·Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual·Victor T Tsang, Shahzad G Raja
Aug 9, 2011·Archives of Medical Research·Thaís de Oliveira FariaIvanita Stefanon
Mar 10, 2016·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·L C LeeJ M Guccione
Feb 7, 2012·NMR in Biomedicine·Tessa GeelenGustav J Strijkers
Jun 21, 2011·Clinical Cardiology·Marcos F MinicucciLeonardo A M Zornoff
Apr 23, 2014·Journal of Cellular Biochemistry·Xintong WangHak-Joon Sung
Apr 11, 2015·Archives of Cardiovascular Diseases·Guillaume ClerfondAlain Furber
Oct 25, 2011·Journal of the American College of Cardiology·Arantxa GonzálezJavier Díez

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.